Effectiveness of direct-acting agents for hepatitis C and liver stiffness changing after sustained virological response.
Flavia F FernandesJuliana PiedadeLivia GuimaraesEstevao P NunesUrsula ChavesRafaela V GoldenzonSandra W CardosoJoana DuarteBeatriz GrinsztejnValdilea G VelosoGustavo PereiraHugo PerazzoPublished in: Journal of gastroenterology and hepatology (2019)
DAAs were highly effective and safe, and LSM significantly decreased after SVR in a real-life cohort in Brazil. The absence of type 2 diabetes and presence of high platelet count were independently associated with LSM decrease post-SVR.